We are live on
!
Find out more
PCM
Polaris Capital Management Portfolio holdings
AUM
$1.06B
1-Year Est. Return
40.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$1.06B
AUM Growth
-$161M
(-13%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-27.53%
Top 10 Holdings %
Top 10 Hldgs %
47.74%
Holding
90
New
6
Increased
25
Reduced
42
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$19.5M |
| 2 |
Cytokinetics
CYTK
|
+$19.2M |
| 3 |
Booking.com
BKNG
|
+$19.1M |
| 4 |
SW
Smurfit Westrock
SW
|
+$11.1M |
| 5 |
Itron
ITRI
|
+$1.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$31M |
| 2 |
United Therapeutics
UTHR
|
+$24.3M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$18.9M |
| 4 |
Arrow Electronics
ARW
|
+$18.1M |
| 5 |
Lantheus
LNTH
|
+$17.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.83% |
| 2 | Healthcare | 26.01% |
| 3 | Consumer Discretionary | 12.31% |
| 4 | Materials | 7.54% |
| 5 | Technology | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exelixis
EXEL
$14.6B
| $1.43M | 0.13% |
26,300
| – | – |
|
77
Harmony Biosciences
HRMY
$2.46B
| $1.31M | 0.12% |
36,100
| – | – |
|
|
AVBC
78
Avidia Bancorp
AVBC
$408M
| $1.31M | 0.12% |
62,600
+22,600
| +57% | +$451K |
|
79
ANI Pharmaceuticals
ANIP
$1.64B
| $1.29M | 0.12% |
15,600
| – | – |
|
80
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.05M | 0.1% |
22,500
| – | – |
|
|
AUGO
81
Aura Minerals Inc
AUGO
$7.12B
| $976K | 0.09% |
+15,500
| New | +$1.22M |
|
82
Amphastar Pharmaceuticals
AMPH
$986M
| $872K | 0.08% |
43,232
| – | – |
|
83
Progress Software
PRGS
$1.81B
| $786K | 0.07% |
23,400
| – | – |
|
84
Credicorp
BAP
$30.4B
| $662K | 0.06% |
1,700
-300
| -15% | -$103K |
|
85
Euronet Worldwide
EEFT
$2.76B
| – | – |
-4,500
| Closed | -$299K |
|
86
First Seacoast Bancorp
FSEA
$80.8M
| – | – |
-90,537
| Closed | -$1.14M |
|
87
Kforce
KFRC
$977M
| – | – |
-16,557
| Closed | -$484K |
|
|
88
MKS Inc
MKSI
$17.6B
| – | – |
-134,700
| Closed | -$31M |
|
89
Winnebago Industries
WGO
$877M
| – | – |
-38,067
| Closed | -$1.18M |
|
90
Wabash National
WNC
$583M
| – | – |
-158,070
| Closed | -$1.36M |
|
Similar funds
BDP
SAM
CIC
PCI
PTC
RPAM
JSC
NAS
Polaris Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Polaris Capital Management held 90 positions worth $1.06B, down 13% from $1.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Polaris Capital Management withdrew a net $292M in Q2 2026, closing 6 positions and reducing 42 holdings. Its most notable exit was MKS Inc, an estimated $31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Polaris Capital Management opened a new position in Adobe worth $16.9M.
- Polaris Capital Management's largest Q2 2026 buy was Adobe: 82,200 shares worth $16.9M.
- Polaris Capital Management added most to Smurfit Westrock in Q2 2026, an estimated $11.1M increase.
- Polaris Capital Management's biggest Q2 2026 reduction was United Therapeutics, cutting an estimated $24.3M.
- Polaris Capital Management fully exited MKS Inc in Q2 2026, selling an estimated $31M.
- Polaris Capital Management's ten largest holdings make up 48% of its $1.06B portfolio in Q2 2026.
- Polaris Capital Management opened 6 new positions and closed 6 in Q2 2026.
- Polaris Capital Management's portfolio value fell 13% quarter-over-quarter to $1.06B.
Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.